--- title: Digital Health Innovation - Speakers | Reuters Events --- [![](https://demo.iv-dev2.co.uk/hubfs/reuters-events-demo/branding/reuters-logo-primary.png)](https://demo.iv-dev2.co.uk/#) [Skip to main content](https://demo.iv-dev2.co.uk/pharma/digital-health-innovation/speakers#main-content) - [Home](https://demo.iv-dev2.co.uk/pharma/digital-health-innovation?hsLang=en-gb) - [Speakers](https://demo.iv-dev2.co.uk/pharma/digital-health-innovation/speakers?hsLang=en-gb) - [Agenda](https://demo.iv-dev2.co.uk/pharma/digital-health-innovation/agenda?hsLang=en-gb) - [Sponsors](https://demo.iv-dev2.co.uk/pharma/digital-health-innovation/sponsors?hsLang=en-gb) - [Partner With Us](https://demo.iv-dev2.co.uk/pharma/digital-health-innovation/partner-with-us?hsLang=en-gb) - [Register](https://demo.iv-dev2.co.uk/pharma/digital-health-innovation/register?hsLang=en-gb) Digital Health InnovationNovember 2027  |  Singapore | #DigitalHealth # Digital Health Innovation speakers [Request your invitation](https://demo.iv-dev2.co.uk/pharma/digital-health-innovation/register?hsLang=en-gb) ## Speaker pledge to ensure actionable takeaways To avoid top-level discussion and ensure you have valuable, impactful learnings to take back to your team, every speaker on this programme has committed to the following: ### A real-world example I will include at least one real-world example to illustrate my point. ### A success and a failure I will share at least one example of a success and one of a failure. ### An actionable next step I will give at least one actionable next step you can implement next week. ![Dr. Rachel Kim](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r1c2.png?upscale=true&width=200&height=200&name=headshot-r1c2.png) ## Dr. Rachel Kim Head of Digital Health ![Johnson & Johnson](https://www.google.com/s2/favicons?domain=jnj.com&sz=128)Johnson & Johnson Rachel builds digital therapeutics and remote monitoring programmes at Johnson & Johnson. ![Dr. Elena Vasquez](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r1c1.png?upscale=true&width=200&height=200&name=headshot-r1c1.png) ## Dr. Elena Vasquez Chief Medical Officer ![Moderna](https://www.google.com/s2/favicons?domain=modernatx.com&sz=128)Moderna Elena oversees clinical strategy across Moderna's infectious disease and oncology pipelines. ![Nadia Haddad](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r3c1.png?upscale=true&width=200&height=200&name=headshot-r3c1.png) ## Nadia Haddad Chief Digital Officer ![Biogen logo](https://www.google.com/s2/favicons?domain=biogen.com&sz=128)Biogen Nadia runs the digital and AI agenda spanning R&D, manufacturing and commercial. ![Andreas Beck](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r2c4.png?upscale=true&width=200&height=200&name=headshot-r2c4.png) ## Andreas Beck Head of Clinical Data Science ![Bayer logo](https://www.google.com/s2/favicons?domain=bayer.com&sz=128)Bayer Andreas builds the data platforms behind Bayer’s decentralised trial programmes. ![Amara Nwosu](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r3c3.png?upscale=true&width=200&height=200&name=headshot-r3c3.png) ## Amara Nwosu Head of Real-World Evidence ![Novo Nordisk logo](https://www.google.com/s2/favicons?domain=novonordisk.com&sz=128)Novo Nordisk Amara builds the evidence base that supports access and reimbursement decisions. ![Grace Adeyemi](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r2c6.png?upscale=true&width=200&height=200&name=headshot-r2c6.png) ## Grace Adeyemi Head of Patient Engagement ![Amgen logo](https://www.google.com/s2/favicons?domain=amgen.com&sz=128)Amgen Grace designs the patient-experience programmes that shape trial recruitment and retention. ![Dr. Yuki Tanaka](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r2c5.png?upscale=true&width=200&height=200&name=headshot-r2c5.png) ## Dr. Yuki Tanaka VP, Regulatory Affairs ![Takeda logo](https://www.google.com/s2/favicons?domain=takeda.com&sz=128)Takeda Yuki leads global regulatory strategy for rare disease and plasma-derived therapies. ![Dr. Julien Marchand](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r3c4.png?upscale=true&width=200&height=200&name=headshot-r3c4.png) ## Dr. Julien Marchand VP, Biostatistics ![Regeneron logo](https://www.google.com/s2/favicons?domain=regeneron.com&sz=128)Regeneron Julien leads adaptive trial design and the statistical methods behind them. ![Dr. Helena Ruiz](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r2c3.png?upscale=true&width=200&height=200&name=headshot-r2c3.png) ## Dr. Helena Ruiz Chief Medical Officer ![Eli Lilly logo](https://www.google.com/s2/favicons?domain=lilly.com&sz=128)Eli Lilly Helena oversees clinical development strategy across metabolic and cardiovascular programmes. ![Dr. Priyanka Menon](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r4c2.png?upscale=true&width=200&height=200&name=headshot-r4c2.png) ## Dr. Priyanka Menon SVP, R&D ![Merck logo](https://www.google.com/s2/favicons?domain=merck.com&sz=128)Merck Oversees a pipeline spanning immunology and rare disease, championing translational science. ![David Osei](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r2c3.png?upscale=true&width=200&height=200&name=headshot-r2c3.png) ## David Osei Director, Patient Access ![GSK logo](https://www.google.com/s2/favicons?domain=gsk.com&sz=128)GSK Designs affordability and access programmes that get therapies to the patients who need them. ![Dr. Sofia Bergman](https://demo.iv-dev2.co.uk/hs-fs/hubfs/reuters-events-demo/images/headshots/headshot-r2c4.png?upscale=true&width=200&height=200&name=headshot-r2c4.png) ## Dr. Sofia Bergman Head of Clinical Data Science ![Roche logo](https://www.google.com/s2/favicons?domain=roche.com&sz=128)Roche Builds the data and AI foundations behind faster, more representative clinical trials. ## See the full programme Exploring how digital therapeutics and telehealth are reshaping patient care at scale. [View the full programme](https://demo.iv-dev2.co.uk/pharma/digital-health-innovation/agenda?hsLang=en-gb) ## Register your interest By registering you'll be the first to know about event updates, speaker confirmations and agenda releases. Fields marked \* are required. I consent to Reuters Events using the personal information provided above to send me marketing communications about its products and services. I understand I can opt-out at any time.